» Articles » PMID: 26833277

Selection Preserves Ubiquitin Specific Protease 4 Alternative Exon Skipping in Therian Mammals

Overview
Journal Sci Rep
Specialty Science
Date 2016 Feb 3
PMID 26833277
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Ubiquitin specific protease 4 (USP4) is a highly networked deubiquitinating enzyme with reported roles in cancer, innate immunity and RNA splicing. In mammals it has two dominant isoforms arising from inclusion or skipping of exon 7 (E7). We evaluated two plausible mechanisms for the generation of these isoforms: (A) E7 skipping due to a long upstream intron and (B) E7 skipping due to inefficient 5' splice sites (5'SS) and/or branchpoint sites (BPS). We then assessed whether E7 alternative splicing is maintained by selective pressure or arose from genetic drift. Both transcript variants were generated from a USP4-E7 minigene construct with short flanking introns, an observation consistent with the second mechanism whereby differential splice signal strengths are the basis of E7 skipping. Optimization of the downstream 5'SS eliminated E7 skipping. Experimental validation of the correlation between 5'SS identity and exon skipping in vertebrates pinpointed the +6 site as the key splicing determinant. Therian mammals invariably display a 5'SS configuration favouring alternative splicing and the resulting isoforms have distinct subcellular localizations. We conclude that alternative splicing of mammalian USP4 is under selective maintenance and that long and short USP4 isoforms may target substrates in various cellular compartments.

Citing Articles

Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes.

Cruz L, Soares P, Correia M Pharmaceuticals (Basel). 2021; 14(9).

PMID: 34577547 PMC: 8469789. DOI: 10.3390/ph14090848.


Spotlight on USP4: Structure, Function, and Regulation.

Hu B, Zhang D, Zhao K, Wang Y, Pei L, Fu Q Front Cell Dev Biol. 2021; 9:595159.

PMID: 33681193 PMC: 7935551. DOI: 10.3389/fcell.2021.595159.


USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target.

Wang Y, Zhou L, Lu J, Jiang B, Liu C, Guo J Cancer Cell Int. 2020; 20:298.

PMID: 32669974 PMC: 7350758. DOI: 10.1186/s12935-020-01391-9.


The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity.

Fielding A, Concannon M, Darling S, Rusilowicz-Jones E, Sacco J, Prior I Oncogene. 2018; 37(17):2326-2342.

PMID: 29429988 PMC: 5916918. DOI: 10.1038/s41388-017-0092-0.


ARSDA: A New Approach for Storing, Transmitting and Analyzing Transcriptomic Data.

Xia X G3 (Bethesda). 2017; 7(12):3839-3848.

PMID: 29079682 PMC: 5714481. DOI: 10.1534/g3.117.300271.


References
1.
Uras I, List T, Nijman S . Ubiquitin-specific protease 4 inhibits mono-ubiquitination of the master growth factor signaling kinase PDK1. PLoS One. 2012; 7(2):e31003. PMC: 3274522. DOI: 10.1371/journal.pone.0031003. View

2.
Zhao B, Schlesiger C, Masucci M, Lindsten K . The ubiquitin specific protease 4 (USP4) is a new player in the Wnt signalling pathway. J Cell Mol Med. 2010; 13(8B):1886-95. PMC: 9181360. DOI: 10.1111/j.1582-4934.2009.00682.x. View

3.
Roy M, Kim N, Xing Y, Lee C . The effect of intron length on exon creation ratios during the evolution of mammalian genomes. RNA. 2008; 14(11):2261-73. PMC: 2578852. DOI: 10.1261/rna.1024908. View

4.
Xing Y, Lee C . Assessing the application of Ka/Ks ratio test to alternatively spliced exons. Bioinformatics. 2005; 21(19):3701-3. DOI: 10.1093/bioinformatics/bti613. View

5.
Klar J, Sobol M, Melberg A, Mabert K, Ameur A, Johansson A . Welander distal myopathy caused by an ancient founder mutation in TIA1 associated with perturbed splicing. Hum Mutat. 2013; 34(4):572-7. DOI: 10.1002/humu.22282. View